Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

80%

8 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
8(88.9%)
N/A
1(11.1%)
9Total
Phase 4(8)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT02436226Phase 4Completed

Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS

Role: lead

NCT02303171Phase 4Unknown

Use of Warfarin After the First Trimester in Pregnant Women With APS

Role: lead

NCT02699437Completed

Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia

Role: lead

NCT02673359Phase 4Unknown

Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Short Cervix and History of PTL and/or MTM

Role: lead

NCT02705222Not ApplicableCompleted

Comparison Between D&C and Hysteroscopy in Management of AUB in Perimenopausal Women

Role: lead

NCT02326051Phase 4Completed

Timing of Initiation of LMWH Administration in Pregnant Women With APS

Role: lead

NCT02699827Phase 4Completed

Adding MgSO4 to Epidural Levobupivacaine in CS for Patients With Preeclampsia

Role: lead

NCT02458963Phase 4Withdrawn

IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS

Role: lead

NCT02456792Phase 4Withdrawn

IVF Versus LOD in Women With CC Resistant PCOS

Role: lead

NCT02338830Phase 4Completed

Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix

Role: lead

All 10 trials loaded